Management ChangeJul 1, 2026, 07:01 AM
X4 Pharmaceuticals Appoints Kelly Gold to Board of Directors
AI Summary
X4 Pharmaceuticals announced the appointment of Kelly Gold to its Board of Directors, effective July 1, 2026. Ms. Gold will serve as an independent director and a member of the Audit Committee, bringing significant financial leadership, capital markets expertise, and a scientific background. The company expects her experience as a public company CFO and deep understanding of the biotech landscape to be valuable as it progresses mavorixafor towards potential approval and commercialization.
Key Highlights
- X4 Pharmaceuticals appointed Kelly Gold to its Board of Directors.
- Ms. Gold's appointment is effective July 1, 2026.
- She will serve as an independent director and member of the Audit Committee.
- Ms. Gold brings financial leadership, capital markets expertise, and a scientific background.
- She is currently the Chief Financial Officer at CAMP4 Therapeutics.
- Previously, she held roles at Biogen and Deutsche Bank.
Price Impact
More from XFOR